Table 3.

Complications and Clinical Outcomes

	All (N = 354)	DRA (n = 176)	TRA (n = 178)	P Value
Bleeding complications	17 (4.8)	8 (4.5)	9 (5.1)	0.822
Access-site-related bleeding	10 (2.8)	4 (2.3)	6 (3.4)	0.750
BARC definition				0.916
Type 1	10 (2.8)	4 (2.3)	6 (3.4)
Type 2	6 (1.7)	3 (1.7)	3 (1.7)
Type 3b	1 (0.3)	1 (0.6)	0 (0.0)
Bleeding type				0.492
Access site	10 (2.8)	4 (2.3)	6 (3.4)
Hemoptysis	1 (0.3)	1 (0.6)	0 (0.0)
Epistaxis	1 (0.3)	0 (0.0)	1 (0.6)
Gingival bleeding	1 (0.3)	0 (0.0)	1 (0.6)
GI bleeding	1 (0.3)	1 (0.6)	0 (0.0)
GU bleeding	3 (0.8)	2 (1.1)	1 (0.6)
In-hospital MACE	3 (0.8)	3 (1.7)	0 (0.0)	0.122
In-hospital death	3 (0.8)	3 (1.7)	0 (0.0)	0.122
Death type
Cardiac death	2	2	0
Noncardiac death	1	1	0
MI related to the target vessel	0	0	0	Not applicable
Target lesion revascularization	0	0	0	Not applicable
Stent thrombosis	0	0	0	Not applicable
One-month follow-up
Follow-up at 1 month	350 (98.9)	173 (98.3)	177 (99.4)	0.370
Access site complication	5 (1.4)	2 (1.2)	3 (1.7)	>0.999
Complication type				0.902
Occlusion	1 (0.3)	0 (0.0)	1 (0.6)
Neuropathy	3 (0.9)	1 (0.6)	2 (1.1)
Hand swelling or pain	1 (0.3)	1 (0.6)	0 (0.0)
MACE at 1 month	4 (1.1)	3 (1.7)	1 (0.6)	0.367
Cardiac death	4 (1.1)	3 (1.7)	1 (0.6)	0.367
MI related to the target vessel	1 (0.3)	1 (0.6)	0 (0.0)	0.494
Target lesion revascularization	1 (0.3)	1 (0.6)	0 (0.0)	0.494
Stent thrombosis	4 (1.1)	3 (1.7)	1 (0.6)	0.367
By duration
Subacute	4 (1.1)	3 (1.7)	1 (0.6)	0.367
By definition				0.424
Definite	1 (0.3)	1 (0.6)	0 (0.0)
Probable	3 (0.9)	2 (1.2)	1 (0.6)

Values are mean ± SD, median (IQR), or n (%).

BARC = Bleeding Academic Research Consortium; MACE = major adverse cardiovascular events; GI = gastrointestinal; GU = genitourinary; other abbreviations as in Table 1.